MTOR and cyst: It was reported that mTOR is activated in cyst-lining cells in human ADPKD kidneys and inhibition of mTOR pathway reverses renal cystogenesis in animal models [20], although clinical trials with rapamycin in human ADPKD patients were disappointing [21].